References

1. Issitt PD et al. Anti-Rh33, the second separable example, also made by a person who made anti-D and has C+ red cells. Transfusion, 1986. [Citation] [RHeference]
2. Gorick B et al. Quantitation of D sites on selected 'weak D' and 'partial D' red cells. Vox Sang, 1993. [Citation] [RHeference]
3. Faas BH et al. Molecular background of VS and weak C expression in blacks. Transfusion, 1997. [Citation] [RHeference]
4. Avent ND et al. Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood, 1997. [Citation] [RHeference]
5. Omi T et al. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype. Biochem Biophys Res Commun, 1999. [Citation] [RHeference]
6. Hyodo H et al. New RhD(IVb) identified in Japanese. Vox Sang, 2000. [Citation] [RHeference]
7. Hyodo H et al. Polymorphisms of RhD(Va) and a new RhD(Va)-like variant found in Japanese individuals. Vox Sang, 2000. [Citation] [RHeference]
8. Okuda H et al. The analysis of nucleotide substitutions, gaps, and recombination events between RHD and RHCE genes through complete sequencing. Biochem Biophys Res Commun, 2000. [Citation] [RHeference]
9. Esteban R et al. RhD epitope expression in a RHD negative individual: characterization of a novel RHCE variant allele. Transfusion Clinique et Biologique, 2001. — Abstract — [RHeference]
10. Kashiwase K et al. E variants found in Japanese and c antigenicity alteration without substitution in the second extracellular loop. Transfusion, 2001. [Citation] [RHeference]
11. Flegel WA et al. Section 1B: Rh flow cytometry. Coordinator's report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol, 2002. [Citation] [RHeference]
12. A. Doscher et al. Six new RHD alleles with previously unknown polymorphisms Transfus Med Hemother , 2003. — Abstract — [RHeference]
13. Noizat-Pirenne F et al. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs. Transfus Clin Biol, 2003. [Citation] [RHeference]
14. Wagner T et al. Anti-D immunization by DEL red blood cells. Transfusion, 2005. [Citation] [RHeference]
15. L. Tilley et al. A novel RhD variant associated with extremely low serological expression of D-antigen Transfusion Medicine, 2005. — Abstract — [RHeference]
16. Doescher A et al. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion, 2005. [Citation] [RHeference]
17. Gassner C et al. Presence of RHD in serologically D-, C/E+ individuals: a European multicenter study. Transfusion, 2005. [Citation] [RHeference]
18. Flegel WA et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion, 2006. [Citation] [RHeference]
19. Pereira JC et al. Prenatal determination of the fetal RhD blood group by multiplex PCR: a 7-year Portuguese experience. Prenat Diagn, 2007. [Citation] [RHeference]
20. Nogues N et al. RHD null alleles in the Spanish population Vox Sanguinis, 2007. — Abstract — [RHeference]
21. MP Martinez Badas et al. Anti-D immunization in a D-positive mother Vox Sanguinis, 2007. — Abstract — [RHeference]
22. Flegel WA et al. DCS-1, DCS-2, and DFV share amino acid substitutions at the extracellular RhD protein vestibule. Transfusion, 2008. [Citation] [RHeference]
23. Flegel WA et al. D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion, 2009. [Citation] [RHeference]
24. J. Pereira et al. RHD Null Alleles in the Portuguese Population Transfusion Medicine, 2009. — Abstract — [RHeference]
25. Dogic V et al. Distribution of weak D types in the Croatian population. Transfus Med, 2011. [Citation] [RHeference]
26. Wagner FF et al. RHD PCR of blood donors in Northern Germany: use of adsorption/elution to determine D antigen status Vox Sanguinis, 2012. — Abstract — [RHeference]
27. Szulman A et al. Investigation of pseudogenes RHDΨ and RHD-CE-D hybrid gene in D-negative blood donors by the real time PCR method. Transfus Apher Sci, 2012. [Citation] [RHeference]
28. F F Wagner et al. Single Adsorption / Elution with Anti-D May Be Insufficient to Determine the D Antigen Status of Very Weak DEL Alleles Transfusion, 2012. — Abstract — [RHeference]
29. von Zabern I et al. DFR-5 is a New Member in the DFR Family of Partial D and Has the Hybrid Structure RHD-CE(3-4)-D Transfus Med Hemother, 2012. — Abstract — [RHeference]
30. Gowland P et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci, 2014. [Citation] [RHeference]
31. Scott SA et al. The RHD(1227G>A) DEL-associated allele is the most prevalent DEL allele in Australian D- blood donors with C+ and/or E+ phenotypes. Transfusion, 2014. [Citation] [RHeference]
32. Wang QP et al. An investigation of secondary anti-D immunisation among phenotypically RhD-negative individuals in the Chinese population. Blood Transfus, 2014. [Citation] [RHeference]
33. A C Gaspardi et al. RHD variants in blood donors from Southeast Brazil. Transfusion, 2015. — Abstract — [RHeference]
34. Lambert MD et al. The second example of alloanti-D in a weak D type 33 individual Vox Sanguinis, 2015. — Abstract — [RHeference]
35. Sippert E et al. Variant RH alleles and Rh immunisation in patients with sickle cell disease. Blood Transfus, 2015. [Citation] [RHeference]
36. Ogasawara K et al. Molecular basis for D- Japanese: identification of novel DEL and D- alleles. Vox Sang, 2015. [Citation] [RHeference]
37. Lukacevic Krstic J et al. Anti-D Antibodies in Pregnant D Variant Antigen Carriers Initially Typed as RhD. Transfus Med Hemother, 2016. [Citation] [RHeference]
38. Srivastava K et al. The DAU cluster: a comparative analysis of 18 RHD alleles, some forming partial D antigens. Transfusion, 2016. [Citation] [RHeference]
39. Ogasawara K et al. Weak D alleles in Japanese: a c.960G>A silent mutation in exon 7 of the RHD gene that affects D expression. Vox Sang, 2016. [Citation] [RHeference]
40. Dezan MR et al. RHD and RHCE genotyping by next-generation sequencing is an effective strategy to identify molecular variants within sickle cell disease patients. Blood Cells Mol Dis, 2017. [Citation] [RHeference]
41. Ouchari M et al. Serologic and molecular characterization of weak D type 29. Transfusion, 2017. [Citation] [RHeference]
42. McGowan EC et al. Diverse and novel RHD variants in Australian blood donors with a weak D phenotype: implication for transfusion management. Vox Sang, 2017. [Citation] [RHeference]
43. Lopez GH et al. Genotyping by sequencing defines independent novel RHD variants for an antenatal patient and a blood donor. Transfusion, 2017. [Citation] [RHeference]
44. Saleheen D et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature, 2017. [Citation] [RHeference]
45. Dezan MR et al. High frequency of variant RHD genotypes among donors and patients of mixed origin with serologic weak-D phenotype. J Clin Lab Anal, 2018. [Citation] [RHeference]
46. S. Lewis et al. Identification of a novel D variant I157S in a patient with alloanti-D Transfusion Medicine, 2018. — Abstract — [RHeference]
47. Schoeman EM et al. Targeted exome sequencing defines novel and rare variants in complex blood group serology cases for a red blood cell reference laboratory setting. Transfusion, 2018. [Citation] [RHeference]
48. C Araujo et al. Serological and Molecular Characterization of Weak D Type 18 in Four Brazilian Families Transfusion, 2018. — Abstract — [RHeference]
49. Dezan MR et al. Evaluation of the applicability and effectiveness of a molecular strategy for identifying weak D and DEL phenotype among D- blood donors of mixed origin exhibiting high frequency of RHD*Ψ. Transfusion, 2018. [Citation] [RHeference]
50. Wagner F. et al. Results of more than ten years testing of RhD negative first time donors by RHD PCR Transfus Med Hemother, 2019. — Abstract — [RHeference]
51. L Castilho et al. RHD*weak D type 3 and production of allo-anti-D in a patient with sickle cell disease (SCD)
 Vox Sanguinis, 2019. — Abstract — [RHeference]
52. Koutsouri T et al. Frequency distribution of RHD alleles among Greek donors with weak D phenotypes demonstrates a distinct pattern in central European countries. Transfus Med, 2019. [Citation] [RHeference]
53. Izaskun Apraiz et al. Performance Evaluation Study of ID RHD XT as a Molecular Tool for RHD Gene Screening in Pooled Blood Samples of Serologically D− C/E+ Donors Transfusion, 2019. — Abstract — [RHeference]
54. Srivastava K et al. NG_007494.1(RHD):c.[4A>T;5G>C;6_7insG] with an RhD-negative phenotype. Transfusion, 2020. [Citation] [RHeference]
55. Aline Floch et al. Understanding anti-D formation in RhD variants through the study of 3D intraprotein interactions manuscript in preparation, 2020. — Article — [RHeference]
56. Safic Stanic H et al. D variants in the population of D-negative blood donors in the north-eastern region of Croatia. Transfus Med, 2021. [Citation] [RHeference]